Inventor
LOBOV IVAN B
US11 patents
Patents
11 patentsUS9265827B2Feb 23, 2016
Anti-PDGFR-beta antibodies and uses thereof
REGENERON PHARMA87 citations97
US9644018B2May 9, 2017
Antibody modulators of APLNR
REGENERON PHARMA13 citations91
US9650444B2May 16, 2017
Anti-PDGFR-beta antibodies and uses thereof
REGENERON PHARMA12 citations83
US10947310B2Mar 16, 2021
Fusion protein comprising apelin and an anti-APLNR antibody
REGENERON PHARMA1 citations72
US10626173B2Apr 21, 2020
Method for treating pathological angiogenesis by administering an antibody that inhibits APLNR
REGENERON PHARMA2 citations72
US10189901B2Jan 29, 2019
Methods for improving cardiac function by administering an antibody that activates APLNR
REGENERON PHARMA2 citations72
US10155811B2Dec 18, 2018
APLNR modulators and uses thereof
REGENERON PHARMA2 citations72
US11642390B2May 9, 2023
Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody
REGENERON PHARMA0 citations61
US11071780B2Jul 27, 2021
Methods and formulations for treating vascular eye diseases using aflibercept and nesvacumab
REGENERON PHARMA0 citations58
US11104730B2Aug 31, 2021
Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors
REGENERON PHARMA0 citations55
US10023642B2Jul 17, 2018
Anti-PDGFR-beta antibodies and uses thereof
REGENERON PHARMA0 citations51